When Should We Stop Treatment With Terlipressin and Albumin for Patients With Hepatorenal Syndrome?

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1710-1711. doi: 10.1016/j.cgh.2018.04.020. Epub 2018 Apr 21.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Acute-On-Chronic Liver Failure*
  • Albumins
  • Hepatorenal Syndrome*
  • Humans
  • Lypressin
  • Terlipressin

Substances

  • Albumins
  • Lypressin
  • Terlipressin